摘要 |
The invention provides a method for the in vitro prognostic evaluation of colorectal, oesophageal or ovarian cancer status from a sample with a monoclonal or polyclonal antibody specific respectively for a selected matrix metalloproteinase and screening for a positive response. The selected matrix metalloproteinase may be a collagenase or a gelatinase, particularly an MMP-1 or an MMP-9. |